Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Assessing Our Progress and Looking Ahead

Posted on April 21st, 2017 by in The Hive

Like many start-ups, Reset Therapeutics has been driven by big ideas, which we have pursued with passion, commitment and accountability. Continue reading “Assessing Our Progress and Looking Ahead” »

Reaxys: Increasing Efficiency in the Lab

Posted on April 19th, 2017 by in Chemistry

Bruce Clapham is Director and Head of Medicinal Chemistry at the San Francisco-based Reset Therapeutics, a start-up dedicated to using the body’s natural circadian system to discover and develop new therapies. “My job is to run the chemistry lab and to be a leader in the design of new molecules Continue reading “Reaxys: Increasing Efficiency in the Lab” »

Adding Talent to the Reset Team

Posted on April 7th, 2017 by in The Hive

Last year was a significant growth year for Reset Therapeutics, in terms of our work and with our team doubling in size. Reset’s success has been due to a strict focus on our proprietary knowledge of how to modify circadian rhythms in cells, tissues and animals using novel small molecules.  Continue reading “Adding Talent to the Reset Team” »

Giving Pharma & Biotech Start-Ups a Leg Up

Posted on February 10th, 2017 by in Pharma R&D

Many of the greatest innovations in the pharma world today are emerging from start-up biotech firms. Acknowledging and empowering these small-but-mighty companies was the simple idea behind The Hive, Continue reading “Giving Pharma & Biotech Start-Ups a Leg Up” »

  1. 1
  2. 2